Striatal dopamine receptors become supersensitive while rats are geven trifluoperazine for six months
Clow, A.; Jenner, P.; Theodorou, A.; Marsden, C.D.
Nature 278(5699): 59-61
1979
ISSN/ISBN: 0028-0836 PMID: 570253 Document Number: 149272
Document emailed within 1 workday
Related Documents
Breese, G.R.; Baumeister, A.; Napier, T.C.; Frye, G.D.; Mueller, R.A. 1985: Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine Journal of Pharmacology and Experimental Therapeutics 235(2): 287-295Dwoskin, L.P.; Zahniser, N.R. 1986: Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors Journal of Pharmacology and Experimental Therapeutics 239(2): 442-453
Hillegaart, V.; Ahlenius, S.; Fowler, C.J.; Magnusson, O. 1988: Increased duration of dopamine receptor antagonist-induced effects on both behaviour and striatal dopamine turnover by repeated testing in rats Pharmacology and Toxicology 63(2): 114-117
Ogawa, N.; Asanuma, M.; Takayama, H.; Sato, H.; Nukina, I. 1990: Effect of flunarizine hydrochloride on striatal D-2 dopamine receptors Rinsho Shinkeigaku 30(11): 1221-1226
Acquas, E.; Wilson, C.; Fibiger, H.C. 1997: Nonstriatal dopamine D1 receptors regulate striatal acetylcholine release in vivo Journal of Pharmacology and Experimental Therapeutics 281(1): 360-368
Rogue, P.; Zwiller, J.; Malviya, A.N.; Vincendon, G. 1990: Phosphorylation by protein kinase C modulates agonist binding to striatal dopamine D2 receptors Biochemistry International 22(3): 575-582
Rubinstein, M.; Muschietti, J.P.; Gershanik, O.; Flawia, M.M.; Stefano, F.J. 1990: Adaptive mechanisms of striatal D1 and D2 dopamine receptors in response to a prolonged reserpine treatment in mice Journal of Pharmacology and Experimental Therapeutics 252(2): 810-816
Gulati, A.; Srimal, R.C.; Dhawan, B.N. 1986: Stereotyped behaviour and striatal dopamine receptors in albino rat and the desert rat (Mastomys natalensis): a comparative study Indian Journal of Experimental Biology 24(4): 248-251
Gnegy, M.; Uzunov, P.; Costa, E. 1977: Participation of an endogenous Ca++-blinding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors Journal of Pharmacology and Experimental Therapeutics 202(3): 558-564
Teng, L.; Crooks, P.A.; Sonsalla, P.K.; Dwoskin, L.P. 1997: Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake Journal of Pharmacology and Experimental Therapeutics 280(3): 1432-1444
Kenny, A.M.; Schneider, M.B.; Baden, D.R.; Pfeiffer, R.F.; Murrin, L.C. 1986: Bromocriptine holiday: effects on dopamine receptors and turning behavior in rats Neurology 36(3): 400-404
Vekshina, N.L. 1992: The properties of the brain dopamine and GABA receptors in rats with chronic alcoholic intoxication with different ethanol withdrawal times Eksperimental'naia i Klinicheskaia Farmakologiia 55(3): 65-67
Gundlach, A.L.; Christie, M.J.; Beart, P.M. 1985: Activation of accumbal and striatal dopamine autoreceptors by some ergoline derivatives Research Communications in Chemical Pathology and Pharmacology 48(1): 149-152
Chishti, M.A.; Fisher, J.P.; Seegal, R.F. 1996: Aroclors 1254 and 1260 reduce dopamine concentrations in rat striatal slices Neurotoxicology 17(3-4): 653-660
Yamada, S.; Takaki, T.; Yokoo, H.; Tanaka, M. 1995: Inhibitory effect of haloperidol on evoked dopamine release from striatal slices of the rat Nihon Shinkei Seishin Yakurigaku Zasshi 15(1): 43-52
Fortune, D.H.; Costall, B.; Naylor, R.J. 1980: Tiapride binds to mouse striatal tissue pre-exposed to dopamine stimulation Journal of Pharmacy and Pharmacology 32(7): 514-517
Fischer, J.F.; Cho, A.K. 1976: Properties of dopamine efflux from rat striatal tissue caused by amphetamine and p-hydroxyamphetamine Proceedings of the Western Pharmacology Society 19: 179-182
Copeland, B.J.; Vogelsberg, V.; Neff, N.H.; Hadjiconstantinou, M. 1996: Protein kinase C activators decrease dopamine uptake into striatal synaptosomes Journal of Pharmacology and Experimental Therapeutics 277(3): 1527-1532
Tadori, Y.; Kobayashi, H. 2014: The therapeutic plasma concentrations of antiparkinson dopamine agonists and their in vitro pharmacology at dopamine receptors Nihon Shinkei Seishin Yakurigaku Zasshi 34(5-6): 127-132
Katzman, R.; Makman, M.H.; Ahn, H.S.; Mishra, R.K.; Gardner, E. 1977: Effects of drugs and lesions on dopamine-stimulated adenylate cyclase: evidence for different classes of dopamine receptors Transactions of the American Neurological Association 102: 76-79